Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients Publisher Pubmed



Tahamtan A1, 2 ; Tavakoliyaraki M3 ; Salimi V4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Infectious Diseases Research Centre, Golestan University of Medical Sciences, Gorgan, Iran
  2. 2. Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  3. 3. Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Expert Review of Respiratory Medicine Published:2020


Abstract

[No abstract available]
Other Related Docs
15. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
19. Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of Icu-Hospitalized Covid-19 Patients, Canadian Journal of Infectious Diseases and Medical Microbiology (2023)
20. Cardiovascular Manifestations in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Cardiovascular and Thoracic Research (2021)
26. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
27. A Case of Multiple Large Left Ventricular Clots in a Patient With Covid-19, International Cardiovascular Research Journal (2021)
34. Dynamic Changes of Lymphocyte Subsets in the Course of Covid-19, International Archives of Allergy and Immunology (2021)
40. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
45. Nanotechnology-Enabled Face Masks for Improved Medical Applications, Nanoengineered Materials for Medical and Healthcare Applications (2025)
47. Transmission Modes of Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2021)